Please use the following form
to request access to the Viveve Hub.
Content provided on this site may not be applicable for every region. Please abide by your regional indication as follows: The Viveve® System is indicated for treatment of the vaginal introitus, after vaginal childbirth, to improve sexual function in Australia, Brazil, Canada, Chile, Colombia, Costa Rica, Hong Kong, Japan, Malaysia, Panama, Philippines, Singapore, and United Arab Emirates. The Viveve System is indicated for treatment of vaginal laxity in Bahrain, EU, Iceland, Korea, Kuwait, Lebanon, Liechtenstein, Norway, Qatar, Switzerland, Turkey, and Ukraine. The Viveve System is indicated for use in General Surgical procedures for electrocoagulation, and hemostasis in Taiwan, Thailand, and the United States.